PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
GANX vs. SEER
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GANX and SEER is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

GANX vs. SEER - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Gain Therapeutics, Inc. (GANX) and Seer, Inc. (SEER). The values are adjusted to include any dividend payments, if applicable.

0.00%50.00%100.00%JulyAugustSeptemberOctoberNovemberDecember
20.92%
35.71%
GANX
SEER

Key characteristics

Sharpe Ratio

GANX:

-0.36

SEER:

0.72

Sortino Ratio

GANX:

0.10

SEER:

1.47

Omega Ratio

GANX:

1.01

SEER:

1.16

Calmar Ratio

GANX:

-0.38

SEER:

0.39

Martin Ratio

GANX:

-0.66

SEER:

2.42

Ulcer Index

GANX:

54.26%

SEER:

15.82%

Daily Std Dev

GANX:

100.31%

SEER:

52.92%

Max Drawdown

GANX:

-94.08%

SEER:

-98.25%

Current Drawdown

GANX:

-90.13%

SEER:

-97.25%

Fundamentals

Market Cap

GANX:

$44.56M

SEER:

$146.24M

EPS

GANX:

-$1.07

SEER:

-$1.30

Total Revenue (TTM)

GANX:

$64.80K

SEER:

$14.26M

Gross Profit (TTM)

GANX:

$90.00

SEER:

$2.11M

EBITDA (TTM)

GANX:

-$21.37M

SEER:

-$92.70M

Returns By Period

In the year-to-date period, GANX achieves a -52.22% return, which is significantly lower than SEER's 19.07% return.


GANX

YTD

-52.22%

1M

-6.02%

6M

20.93%

1Y

-37.60%

5Y*

N/A

10Y*

N/A

SEER

YTD

19.07%

1M

0.87%

6M

35.88%

1Y

32.00%

5Y*

N/A

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

GANX vs. SEER - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Gain Therapeutics, Inc. (GANX) and Seer, Inc. (SEER). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for GANX, currently valued at -0.36, compared to the broader market-4.00-2.000.002.00-0.360.72
The chart of Sortino ratio for GANX, currently valued at 0.10, compared to the broader market-4.00-2.000.002.004.000.101.47
The chart of Omega ratio for GANX, currently valued at 1.01, compared to the broader market0.501.001.502.001.011.16
The chart of Calmar ratio for GANX, currently valued at -0.38, compared to the broader market0.002.004.006.00-0.380.39
The chart of Martin ratio for GANX, currently valued at -0.66, compared to the broader market-5.000.005.0010.0015.0020.0025.00-0.662.42
GANX
SEER

The current GANX Sharpe Ratio is -0.36, which is lower than the SEER Sharpe Ratio of 0.72. The chart below compares the historical Sharpe Ratios of GANX and SEER, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00JulyAugustSeptemberOctoberNovemberDecember
-0.36
0.72
GANX
SEER

Dividends

GANX vs. SEER - Dividend Comparison

Neither GANX nor SEER has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

GANX vs. SEER - Drawdown Comparison

The maximum GANX drawdown since its inception was -94.08%, roughly equal to the maximum SEER drawdown of -98.25%. Use the drawdown chart below to compare losses from any high point for GANX and SEER. For additional features, visit the drawdowns tool.


-95.00%-90.00%-85.00%-80.00%JulyAugustSeptemberOctoberNovemberDecember
-90.13%
-95.94%
GANX
SEER

Volatility

GANX vs. SEER - Volatility Comparison

Gain Therapeutics, Inc. (GANX) has a higher volatility of 28.32% compared to Seer, Inc. (SEER) at 11.16%. This indicates that GANX's price experiences larger fluctuations and is considered to be riskier than SEER based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%JulyAugustSeptemberOctoberNovemberDecember
28.32%
11.16%
GANX
SEER

Financials

GANX vs. SEER - Financials Comparison

This section allows you to compare key financial metrics between Gain Therapeutics, Inc. and Seer, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab